- Last Updated: 02 January 2013 02 January 2013
Invest in ME (IiME) is an independent UK charity campaigning for bio-medical research into Myalgic Encephalomyelitis (M.E.), as defined by WHO-ICD-10-G93.3. Invest in ME are one of the founding members of The European ME Alliance (http://www.euro-me.org).
This organization provides links nationwide (for the UK) as well as internationally, including The Journal of IiME (current and prior issues).
In 2012, they released this comprehensive 108 page article titled, THE IMMUNOLOGICAL BASIS OF ME/CFS: what is already known?, (original source: CO-CURE). A compilation of documented immune system abnormalities in ME/CFS from 1983-2011 by Margaret Williams, published in the Journal of Invest in ME, Vol 6 Issue 1, 29-98 (June 2012). This article serves as an important resource for researchers, clinicians and patients.
To view and download previous journals, click on The Journal of IiME. To learn more about this organization and current events, go to Invest in ME (IiME) home page.
Summary of the 7th Invest in ME International ME/CFS Conference 2012 report (IIMEC7 - June 1, 2012 London, UK) by Rosamund Vallings, MNZM, MBBS, of the Associated New Zealand ME Society.
Notice about names
The Massachusetts ME/CFS & FM Association would like to clarify the use of the various acronyms for Chronic Fatigue Syndrome (CFS), Chronic Fatigue & Immune Dysfunction Syndrome (CFIDS) and Myalgic Encephalomyelitis (ME) on this site. When we generate our own articles on the illness, we will refer to it as ME/CFS, the term now generally used in the United States. When we are reporting on someone else’s report, we will use the term they use. The National Institutes of Health (NIH) and other federal agencies, including the CDC, are currently using ME/CFS.
Massachusetts ME/CFS & FM Association changed its name in July, 2018, to reflect this consensus.